Morgan Stanley
ENTA icon

Morgan Stanley’s Enanta Pharmaceuticals ENTA Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$2.17M Sell
286,526
-198,965
-41% -$1.5M ﹤0.01% 4647
2025
Q1
$2.68M Sell
485,491
-736,104
-60% -$4.06M ﹤0.01% 4421
2024
Q4
$7.02M Buy
1,221,595
+118,743
+11% +$683K ﹤0.01% 3698
2024
Q3
$11.4M Sell
1,102,852
-353,707
-24% -$3.66M ﹤0.01% 3326
2024
Q2
$18.9M Sell
1,456,559
-588,586
-29% -$7.63M ﹤0.01% 2726
2024
Q1
$35.7M Sell
2,045,145
-300,971
-13% -$5.25M ﹤0.01% 2080
2023
Q4
$22.1M Buy
2,346,116
+1,781,550
+316% +$16.8M ﹤0.01% 3238
2023
Q3
$6.31M Buy
564,566
+257,264
+84% +$2.87M ﹤0.01% 3547
2023
Q2
$6.58M Buy
307,302
+175,354
+133% +$3.75M ﹤0.01% 3554
2023
Q1
$5.34M Sell
131,948
-6,577
-5% -$266K ﹤0.01% 3732
2022
Q4
$6.44M Sell
138,525
-43,149
-24% -$2.01M ﹤0.01% 3508
2022
Q3
$9.42M Sell
181,674
-63,200
-26% -$3.28M ﹤0.01% 3043
2022
Q2
$11.6M Buy
244,874
+78,326
+47% +$3.7M ﹤0.01% 2913
2022
Q1
$11.9M Buy
166,548
+40,479
+32% +$2.88M ﹤0.01% 2706
2021
Q4
$9.43M Sell
126,069
-36,163
-22% -$2.7M ﹤0.01% 3009
2021
Q3
$9.22M Sell
162,232
-13,975
-8% -$794K ﹤0.01% 2993
2021
Q2
$7.76M Buy
176,207
+30,356
+21% +$1.34M ﹤0.01% 3286
2021
Q1
$7.19M Sell
145,851
-12,305
-8% -$607K ﹤0.01% 3020
2020
Q4
$6.66M Buy
158,156
+67,901
+75% +$2.86M ﹤0.01% 2950
2020
Q3
$4.13M Buy
90,255
+27,983
+45% +$1.28M ﹤0.01% 2897
2020
Q2
$3.13M Sell
62,272
-5,896
-9% -$296K ﹤0.01% 3143
2020
Q1
$3.51M Sell
68,168
-167,990
-71% -$8.64M ﹤0.01% 2803
2019
Q4
$14.6M Buy
236,158
+69,848
+42% +$4.32M ﹤0.01% 1974
2019
Q3
$9.99M Buy
166,310
+57,346
+53% +$3.45M ﹤0.01% 2128
2019
Q2
$9.19M Buy
108,964
+31,335
+40% +$2.64M ﹤0.01% 2257
2019
Q1
$7.42M Sell
77,629
-114,507
-60% -$10.9M ﹤0.01% 2335
2018
Q4
$13.6M Buy
192,136
+152,246
+382% +$10.8M ﹤0.01% 1803
2018
Q3
$3.41M Sell
39,890
-11,877
-23% -$1.02M ﹤0.01% 3567
2018
Q2
$6M Sell
51,767
-5,808
-10% -$673K ﹤0.01% 2944
2018
Q1
$4.66M Buy
57,575
+10,806
+23% +$874K ﹤0.01% 3101
2017
Q4
$2.75M Buy
46,769
+12,774
+38% +$750K ﹤0.01% 3738
2017
Q3
$1.59M Buy
33,995
+3,155
+10% +$148K ﹤0.01% 4082
2017
Q2
$1.11M Sell
30,840
-7,586
-20% -$273K ﹤0.01% 4297
2017
Q1
$1.18M Sell
38,426
-11,834
-24% -$365K ﹤0.01% 4253
2016
Q4
$1.68M Buy
50,260
+45,008
+857% +$1.51M ﹤0.01% 4072
2016
Q3
$140K Sell
5,252
-3,674
-41% -$97.9K ﹤0.01% 5165
2016
Q2
$196K Buy
8,926
+2,044
+30% +$44.9K ﹤0.01% 4947
2016
Q1
$202K Sell
6,882
-3,872
-36% -$114K ﹤0.01% 4972
2015
Q4
$356K Buy
10,754
+6,655
+162% +$220K ﹤0.01% 4762
2015
Q3
$148K Sell
4,099
-917
-18% -$33.1K ﹤0.01% 5234
2015
Q2
$226K Sell
5,016
-3,679
-42% -$166K ﹤0.01% 5175
2015
Q1
$266K Sell
8,695
-2,780
-24% -$85K ﹤0.01% 5049
2014
Q4
$584K Buy
11,475
+6,957
+154% +$354K ﹤0.01% 4559
2014
Q3
$179K Sell
4,518
-311
-6% -$12.3K ﹤0.01% 5201
2014
Q2
$208K Sell
4,829
-390
-7% -$16.8K ﹤0.01% 5132
2014
Q1
$208K Sell
5,219
-1,006
-16% -$40.1K ﹤0.01% 5098
2013
Q4
$170K Buy
+6,225
New +$170K ﹤0.01% 5099
2013
Q3
Sell
-43,678
Closed -$773K 5335
2013
Q2
$773K Buy
+43,678
New +$773K ﹤0.01% 3928